Director, Pharmacometrics & Systems Pharmacology
Pfizer, Inc.
tempe, Arizona, United States
Luke Fostvedt is a Director in the Pharmacometrics and Systems Pharmacology group at Pfizer. He earned his PhD in Statistics from Iowa State University in 2014. He spent the first 5 years of his career in the Oncology Clinical Pharmacology group at Pfizer before switching into Inflammation and Immunology. He has been involved with the Statistics and Pharmacometrics SIG since 2018 and served as co-chair from 2021-2023 and past chair in 2024.
Disclosure(s): Pfizer Inc: Employment (Ongoing)
What is the future and impact of artificial intelligence and machine learning (AI/ML) in each SIGs
Wednesday, November 13, 2024
9:00 AM – 10:30 AM MST
The Practical Bayesian: How Bayesian Methodology is Incorporated into Clinical Drug Development
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
